§ 130A-453.41.  Definitions.

The following definitions apply in this Article:

(1) DEHP. - Di(2-ethylhexyl) phthalate.

(2) Health care practitioner. - An individual who is authorized to practice some component of the healing arts by a license, permit, certificate, or registration issued by a State licensing agency or board.

(3) Intentionally added DEHP. - DEHP that a manufacturer has intentionally added to a product and that has a functional or technical effect on the product.

(4) Intravenous solution container. - A container used to house medicine, fluid, or nutrition therapy that is intravenously delivered to a patient in a hospital, outpatient facility, or other health care facility.

(5) Intravenous tubing. - Tubing used to intravenously administer fluids, medication, or nutrients directly to an adult, child, or infant.

(6) Ortho-phthalate. - A class of chemicals that are esters of ortho-phthalic acid, including DEHP or any of the following:

a. Benzyl butyl phthalate (BBP).

b. Dibutyl phthalate (DBP).

c. Dicyclohexyl phthalate (DCHP).

d. Diethyl phthalate (DEP).

e. Diisobutyl phthalate (DIBP).

f. Diisodecyl phthalate (DIDP).

g. Diisononyl phthalate (DINP).

h. Di-n-hexyl phthalate (DnHP).

i. Di-n-octyl phthalate (DNOP).

j. Di-n-pentyl phthalate (DnPP).

k. Diisoheptyl phthalate (DIHP).

(7) Unintentionally added DEHP. - DEHP in an intravenous solution container or intravenous tubing product that is not used for functional or technical effect on the product.  (2025-60, s. 3(a).)